November 5, 2025

Immunogenik strengthens U.S. clinical and investor readiness through strategic partnership with HITLAB

Immunogenik has won the 2025 Cade Prize for Inventivity in the technology category

Immunogenik recognized as Cade Prize finalist

First-in-human clinical trial to test CAR T cell therapy for pediatric gliomas

University of Florida researchers have launched a first-in-human clinical trial to test a novel immunotherapy treatment for children with an aggressive type of brain tumor.

Immunogenik is awarded its second NCI/NIH STTR grant

Enhance Cancer Therapeutics with 3-in-1 CAR T Cells

Immunogenik is awarded its first NCI/NIH STTR grant

Advancing Cancer Therapy: Developing Antibody Blockade Targeting a Novel Immune Checkpoint, LAIR1/CD305

UF to test novel CAR-modified T-cell technique in clinical trial for glioblastoma

New study shows modified T cells enhance effectiveness of immuno- therapy in tumors

November 5, 2025

Immunogenik strengthens U.S. clinical and investor readiness through strategic partnership with HITLAB

October 14, 2025

Immunogenik has won the 2025 Cade Prize for Inventivity in the technology category

August 21, 2025

Immunogenik recognized as Cade Prize finalist

August 6, 2025

First-in-human clinical trial to test CAR T cell therapy for pediatric gliomas

June 24, 2025

Immunogenik is awarded its second NCI/NIH STTR grant

June 9, 2025

Immunogenik is awarded its first NCI/NIH STTR grant

April 18, 2022

UF to test novel CAR-modified T-cell technique in clinical trial for glioblastoma

November 18, 2019

New study shows modified T cells enhance effectiveness of immuno- therapy in tumors